Clinical Trial Update: Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate [Phase 2, Phase 3]

View source ↗

Summary

The update reports safety and efficacy results from a Phase 2/3 trial of adalimumab in adult Chinese patients with rheumatoid arthritis treated with methotrexat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2009-12-30